Premium
Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled‐release carbamazepine in noninferiority epilepsy monotherapy trials: How much “fair” is “fair”?
Author(s) -
Brigo Francesco,
Lattanzi Simona
Publication year - 2018
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/epi.14035
Subject(s) - lacosamide , medicine , carbamazepine , dose , levetiracetam , randomized controlled trial , epilepsy , oxcarbazepine , zonisamide , perampanel , clinical trial , pharmacology , adverse effect , topiramate , psychiatry